Prophylactic Antidepressant Treatment in Patients With Hepatitis C on Antiviral Therapy: A Double-Blind, Placebo-Controlled Trial

BACKGROUND: Approximately one-third of patients undergoing interferon-α (IFN-α) therapy for treatment of the hepatitis C virus (HCV) develop major depression, which decreases functioning and may lead to the reduction or discontinuation of treatment. OBJECTIVE: The authors examined the efficacy of ci...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Morasco, Benjamin J., Loftis, Jennifer M., Indest, David W., Ruimy, Samantha, Davison, John W., Felker, Bradford, Hauser, Peter
Формат: Artigo
Язык:Inglês
Опубликовано: 2010
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2994596/
https://ncbi.nlm.nih.gov/pubmed/20833939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.psy.51.5.401
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы